₹0.45
(Market cap
₹31 Cr
Revenue (TTM)
₹80 Cr
P/E Ratio
6.5
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
11.1 %
-
ROCE
15.8 %
-
Industry P/E
33.64
-
EV/EBITDA
4.2
-
Debt to Equity
0.3
-
Book Value
₹13.4
-
EPS
₹1.5
-
Face value
10
-
Shares outstanding
32,995,323
7 Years Aggregate
CFO
₹-7.53 Cr
EBITDA
₹27.41 Cr
Net Profit
₹14.28 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
JFL Life Sciences
| -20.8 | 0.5 | -10.0 | -48.2 | -8.8 | -- | -- |
|
BSE Healthcare
| 7.0 | 4.1 | 5.8 | 9.1 | 25.2 | 13.6 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
JFL Life Sciences
| -59.2 | 123.6 | 22.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
JFL Life Sciences
|
9.5 | 31.2 | 80.1 | 4.8 | 10.5 | 11.8 | 6.5 | 0.7 |
| 2,931.0 | 36,667.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 34.7 | 8.1 | |
| 8,729.0 | 21,810.6 | 2,275.6 | 187.5 | 10.3 | 22.9 | 116.3 | 25.0 | |
| 1,998.9 | 15,175.0 | 2,187.2 | 649.7 | 31.5 | 19 | 23.7 | 4.2 | |
| 1,678.3 | 10,299.4 | 1,196.4 | 149.4 | -- | 27.5 | 55.6 | 13.8 | |
| 1,378.4 | 19,114.0 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.9 | 4.9 | |
| 2,140.2 | 34,368.4 | 4,147.8 | 709.5 | 22.3 | 19.1 | 48.4 | 8.3 | |
| 4,515.3 | 20,620.6 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.5 | 4.9 | |
| 6,063.0 | 10,069.6 | 1,408.0 | 326.9 | 30.8 | 57.1 | 30.8 | 19.2 | |
| 1,094.1 | 10,089.7 | 4,858.7 | 574.1 | 14.9 | 19.7 | 18.1 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About JFL Life Sciences
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
2010
-
Chairman
Smiral Ashwinkumar Patel
-
Managing Director
Smiral Ashwinkumar Patel
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about JFL Life Sciences Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for JFL Life Sciences
What is the current share price of JFL Life Sciences Ltd Today?
The share price of JFL Life Sciences Ltd is ₹9.45 (NSE) as of 01-Jun-2026 IST. JFL Life Sciences Ltd has given a return of -8.84% in the last 3 years.
What is the current PB & PE ratio of JFL Life Sciences Ltd?
The P/E ratio of JFL Life Sciences Ltd is 6.47 times as on 01-Jun-2026, a 81 discount to its peers’ median range of 33.64 times.
The P/B ratio of JFL Life Sciences Ltd is 0.71 times as on 01-Jun-2026, a 85 discount to its peers’ median range of 4.76 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.84
|
1.46
|
|
2024
|
4.37
|
1.22
|
|
2023
|
4.31
|
1.12
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of JFL Life Sciences Ltd?
The 52-week high and low of JFL Life Sciences Ltd are Rs 18.76 and Rs 8.55 as of 01-Jun-2026.
What is the market cap of JFL Life Sciences Ltd?
JFL Life Sciences Ltd has a market capitalisation of ₹ 31 Cr as on 01-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in JFL Life Sciences Ltd?
Before investing in JFL Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.